News
-
AHA wins 6CPA contract
Tuesday | Oct 30 2018Australian Healthcare Associates (AHA) has been awarded a services agreement by the Australian Government to administer the 23 Community Pharmacy Programs funded under the Sixth Community Pharmacy Agreement (PD breaking news).
-
2018 PATY winner named
Tuesday | Oct 30 2018LAST weekend's Pharmacy Assistant National Conference on the Gold Coast saw Alice Vanderpol from Moama Village Pharmacy in NSW named as the 2018 Pharmacy Guild of Australia/Maxigesic Pharmacy Assistant of the Year.
-
Tribunal rulings on Register
Tuesday | Oct 30 2018THE Australian Health Practitioner Regulation Agency has confirmed changes to the National Register of practitioners, which will see any publicly available tribunal and court decisions linked to individual health professional records.
-
Paris promotion
Tuesday | Oct 30 2018DERMAL Therapy is offering pharmacy customers the opportunity to win a trip to Paris, with pharmacies encouraged to stock up on the products to give their clients more chances to win.
-
Willach DAA launch
Tuesday | Oct 30 2018WILLACH is today formally launching new Consis Automated Tablet Packagers (ATP), with the systems expected to "shake up the Dose Administration Aids market".
-
Big Penis USA and more TGA drug alerts
Tuesday | Oct 30 2018FAKE and illegal body-building, weight-loss and erectile dysfunction products have entered the Australian market via online purchases, the Therapeutic Goods Administration (TGA) has warned.
-
MA appointment
Tuesday | Oct 30 2018MEDICINES Australia has named Jamie Snashall as its new Director of Public Affairs.
-
Keytruda PBS for LC
Tuesday | Oct 30 2018MINISTER for Health Greg Hunt has announced the funding of immunotherapy medicine Keytruda (pembrolizumab) for first-line treatment of metastatic non-small cell lung cancer (NSCLC) to take effect 01 Nov.
-
AZ in the kitchen
Tuesday | Oct 30 2018ASTRAZENECA has formed a partnership with the Stephanie Alexander Kitchen Garden Foundation to develop an integrated kitchen garden program for secondary schools in Australia.
-
Zytiga patent loss
Tuesday | Oct 30 2018JOHNSON & Johnson has lost a key court case in New Jersey, USA, opening up the market for its Zytiga prostate cancer drug to generic competition when the patent lapses tomorrow.